These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 21075170)

  • 21. The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress.
    Kawaguchi Y; Kovacs JJ; McLaurin A; Vance JM; Ito A; Yao TP
    Cell; 2003 Dec; 115(6):727-38. PubMed ID: 14675537
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impaired ferritin mRNA translation in primary erythroid progenitors: shift to iron-dependent regulation by the v-ErbA oncoprotein.
    Mikulits W; Schranzhofer M; Bauer A; Dolznig H; Lobmayr L; Infante AA; Beug H; Müllner EW
    Blood; 1999 Dec; 94(12):4321-32. PubMed ID: 10590077
    [TBL] [Abstract][Full Text] [Related]  

  • 23. v-erbA oncogene activation entails the loss of hormone-dependent regulator activity of c-erbA.
    Zenke M; Muñoz A; Sap J; Vennström B; Beug H
    Cell; 1990 Jun; 61(6):1035-49. PubMed ID: 1972036
    [TBL] [Abstract][Full Text] [Related]  

  • 24. V-erba homodimers mediate the potent dominant negative activity of v-erba on everted repeats.
    Zubkova I; Subauste JS
    Mol Biol Rep; 2004 Jun; 31(2):131-7. PubMed ID: 15293789
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Presenilin-binding protein forms aggresomes in monkey kidney COS-7 cells.
    Namekata K; Nishimura N; Kimura H
    J Neurochem; 2002 Aug; 82(4):819-27. PubMed ID: 12358787
    [TBL] [Abstract][Full Text] [Related]  

  • 26. v-erbA acts on retinoic acid receptors in immature avian erythroid cells.
    Sande S; Sharif M; Chen H; Privalsky M
    J Virol; 1993 Feb; 67(2):1067-74. PubMed ID: 8093487
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A choice between transcriptional enhancement and repression by the v-erbA oncoprotein governed by one nucleotide in a thyroid hormone responsive half site.
    Andersson ML; Vennström B
    Oncogene; 2000 Jul; 19(32):3563-9. PubMed ID: 10951561
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of oncoprotein v-erbA on thyroid hormone-regulated genes in hepatocytes and their potential role in hepatocellular carcinoma.
    Ventura-Holman T; Mamoon A; Subauste MC; Subauste JS
    Mol Biol Rep; 2011 Feb; 38(2):1137-44. PubMed ID: 20571909
    [TBL] [Abstract][Full Text] [Related]  

  • 29. UCH-L1 aggresome formation in response to proteasome impairment indicates a role in inclusion formation in Parkinson's disease.
    Ardley HC; Scott GB; Rose SA; Tan NG; Robinson PA
    J Neurochem; 2004 Jul; 90(2):379-91. PubMed ID: 15228595
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunohistochemical localization of aggresomal proteins in glial cytoplasmic inclusions in multiple system atrophy.
    Chiba Y; Takei S; Kawamura N; Kawaguchi Y; Sasaki K; Hasegawa-Ishii S; Furukawa A; Hosokawa M; Shimada A
    Neuropathol Appl Neurobiol; 2012 Oct; 38(6):559-71. PubMed ID: 22013984
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of a domain required for oncogenic activity and transcriptional suppression by v-erbA and thyroid-hormone receptor alpha.
    Damm K; Evans RM
    Proc Natl Acad Sci U S A; 1993 Nov; 90(22):10668-72. PubMed ID: 7902566
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of HDAC6 modifies tau inclusion body formation and impairs autophagic clearance.
    Leyk J; Goldbaum O; Noack M; Richter-Landsberg C
    J Mol Neurosci; 2015 Apr; 55(4):1031-46. PubMed ID: 25434725
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The thyroid hormone receptor functions as a ligand-operated developmental switch between proliferation and differentiation of erythroid progenitors.
    Bauer A; Mikulits W; Lagger G; Stengl G; Brosch G; Beug H
    EMBO J; 1998 Aug; 17(15):4291-303. PubMed ID: 9687498
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thyroid hormone receptor, v-ErbA, and chromatin.
    Wolffe AP; Collingwood TN; Li Q; Yee J; Urnov F; Shi YB
    Vitam Horm; 2000; 58():449-92. PubMed ID: 10668407
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aggresomes protect cells by enhancing the degradation of toxic polyglutamine-containing protein.
    Taylor JP; Tanaka F; Robitschek J; Sandoval CM; Taye A; Markovic-Plese S; Fischbeck KH
    Hum Mol Genet; 2003 Apr; 12(7):749-57. PubMed ID: 12651870
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A conserved C-terminal sequence that is deleted in v-ErbA is essential for the biological activities of c-ErbA (the thyroid hormone receptor).
    Saatcioglu F; Bartunek P; Deng T; Zenke M; Karin M
    Mol Cell Biol; 1993 Jun; 13(6):3675-85. PubMed ID: 8098843
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dimerization of v-erbA on inverted repeats.
    Zubkova I; Subauste JS
    Biochem Biophys Res Commun; 2002 May; 294(1):35-41. PubMed ID: 12054736
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A critical role for CHIP in the aggresome pathway.
    Sha Y; Pandit L; Zeng S; Eissa NT
    Mol Cell Biol; 2009 Jan; 29(1):116-28. PubMed ID: 18955503
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Roles of v-erbA homodimers and heterodimers in mediating dominant negative activity by v-erbA.
    Yen PM; Ikeda M; Brubaker JH; Forgione M; Sugawara A; Chin WW
    J Biol Chem; 1994 Jan; 269(2):903-9. PubMed ID: 7904604
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transcriptional repression of band 3 and CAII in v-erbA transformed erythroblasts accounts for an important part of the leukaemic phenotype.
    Fuerstenberg S; Leitner I; Schroeder C; Schwarz H; Vennström B; Beug H
    EMBO J; 1992 Sep; 11(9):3355-65. PubMed ID: 1354613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.